Decreased PCSK9 expression in human hepatocellular carcinoma.
about
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaPro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells.Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9)
P2860
Decreased PCSK9 expression in human hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Decreased PCSK9 expression in human hepatocellular carcinoma.
@ast
Decreased PCSK9 expression in human hepatocellular carcinoma.
@en
type
label
Decreased PCSK9 expression in human hepatocellular carcinoma.
@ast
Decreased PCSK9 expression in human hepatocellular carcinoma.
@en
prefLabel
Decreased PCSK9 expression in human hepatocellular carcinoma.
@ast
Decreased PCSK9 expression in human hepatocellular carcinoma.
@en
P2093
P2860
P50
P1433
P1476
Decreased PCSK9 expression in human hepatocellular carcinoma
@en
P2093
Janet Kwan
Jeanne Bouteaud
Mamatha Bhat
Marc Deschenes
Mary Maluccio
Peter Metrakos
Peter Siegel
Ramila Amre
Reid Aikin
Sarita Negi
P2860
P2888
P356
10.1186/S12876-015-0371-6
P407
P577
2015-12-16T00:00:00Z